EMEA-002233-PIP01-17-M01
Key facts
Active substance |
Dasiglucagon
|
Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
Decision number |
P/0393/2021
|
PIP number |
EMEA-002233-PIP01-17-M01
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of hypoglycaemia
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Zealand Pharma A/S
E-mail: info@zealandpharma.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|